Now under Balchem, Kappa Bioscience to exhibit at Vitafoods 2023
The company will demonstrate its synergies with other ingredients in Balchem’s portfolio.
Following its acquisition by Balchem Human Nutrition & Health, vitamin K2 supplier Kappa Bioscience (Oslo, Norway) will be an exhibitor at the Vitafoods Europe trade show taking place in Geneva, Switzerland, on May 9-12, at Booth J80. The company will demonstrate its synergies with other ingredients in Balchem’s portfolio.
For instance, Kappa will highlight how its K2Vital Delta double-encapsulated vitamin K2 MK-7 ingredient can pair with Balchem’s Albion Minerals organic mineral amino acid chelates to create opportunities in cardiovascular and bone health. The company touts K2Vital Delta as “the world’s only patented microencapsulated vitamin K2 preparation, which is optimally stable [and] supported in over 400 tests for mineral formulations.”
Other flagship ingredients from Balchem that will be on display at Vitafoods are OptiMSM methylsufonylmethane for joint health, beauty-from-within, and exercise recovery; and VitaCholine, a choline ingredient supporting brain function, normal lipid and homocysteine metabolism, liver function, and prenatal and infant health.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
